28-02-2013

Definiens announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as Chief Medical Officer (CMO). Professor Huss brings significant expertise in pathology and will play a key role in expanding Definiens’ leading position in image and data analysis for Digital ...

more

30-01-2013

Cellmid Limited has completed its first in-life diabetic nephropathy study with the Company’s anti-midkine antibodies (MK-Ab) in a mouse model of the disease. Two of Cellmid’s proprietary MK-Ab’s were tested. Both antibodies reduced kidney damage significantly, as assessed by functional and ...

more

GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation

05-12-2012

Being the first in Europe, the Next Generation Sequencing Laboratories of the Constance Genome and Diagnostics Centre has been accredited according to ISO 17025 from the national accreditation body for the Federal Republic of Germany (DAkks). The independent governmental institution has ...

more

29-11-2012

Aspireo Pharmaceuticals Limited announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion on an application for orphan medicinal product status for Aspireo’s Somatoprim (DG3173) for the treatment of acromegaly.The ...

more

20-11-2012

Definiens AG announced that Dr. Gerald Möller, has joined the company's supervisory board as an independent member and has been appointed chairman. Following the recent financing round, Dr. Möller will guide the expansion of Definiens' current business and the development and ...

more

09-11-2012

Rentschler Biotechnologie GmbH has expanded its management board. Reiner Winkelbauer, who has been the company's Commercial Manager for the past four years, was appointed Managing Director of Finances. He was previously the Controlling and Chief Financial Officer of AEG in Ulm and later ...

more

29-10-2012

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with Paranta Biosciences Ltd of Melbourne , Australia.The contract covers the process development and cGMP manufacture by DSM ...

more

26-10-2012

Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of ...

more

25-10-2012

Sartorius Stedim Biotech has appointed Stefan Schlack as Senior Vice President of Marketing. In his new position, Schlack, who is an experienced Sartorius employee, will assume responsibility for all marketing and product management activities.Stefan Schlack holds a university degree in ...

more

23-10-2012

NovAliX has announced that it has appointed pharma research executive Dr Luc Van Hijfte as CSO Drug Discovery.Dr. Van Hijfte brings a wealth of experience in pharmaceutical research with over 25 years spent in drug discovery. He joined from Janssen, a J&J company, where he served as Head of ...

more